Cargando…
Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission
AIM: While evidence‐based antidepressant treatment is available for major depressive disorder, standard approaches for discontinuation of antidepressants after remission have not yet been established. Decision aids are structured clinical tools that facilitate shared decision‐making between patients...
Autores principales: | Aoki, Yumi, Takaesu, Yoshikazu, Baba, Hajime, Iga, Jun‐ichi, Hori, Hikaru, Inoue, Takeshi, Mishima, Kazuo, Tajika, Aran, Kato, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515698/ https://www.ncbi.nlm.nih.gov/pubmed/35775506 http://dx.doi.org/10.1002/npr2.12269 |
Ejemplares similares
-
Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
por: Kato, Masaki, et al.
Publicado: (2020) -
Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic
por: Aoki, Yumi, et al.
Publicado: (2023) -
Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics
por: Aoki, Yumi, et al.
Publicado: (2021) -
Attitudes and Difficulties Associated with Benzodiazepine Discontinuation
por: Takeshima, Masahiro, et al.
Publicado: (2022) -
Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia
por: Aoki, Yumi, et al.
Publicado: (2023)